0001209191-22-002690.txt : 20220110 0001209191-22-002690.hdr.sgml : 20220110 20220110161901 ACCESSION NUMBER: 0001209191-22-002690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220110 DATE AS OF CHANGE: 20220110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearce Catherine CENTRAL INDEX KEY: 0001898815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41201 FILM NUMBER: 22521476 MAIL ADDRESS: STREET 1: C/O CINCOR PHARMA, INC. STREET 2: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CinCor Pharma, Inc. CENTRAL INDEX KEY: 0001868734 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 8445311834 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-06 0 0001868734 CinCor Pharma, Inc. CINC 0001898815 Pearce Catherine C/O CINCOR PHARMA, INC 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Operating Officer Restricted Stock Units 2022-01-06 4 A 0 26471 0.00 A Common Stock 26471 26471 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date. /s/ Cathy Rude, Attorney-in-Fact 2022-01-10